These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 9797224)

  • 1. Mutations in Bartonella bacilliformis gyrB confer resistance to coumermycin A1.
    Battisti JM; Smitherman LS; Samuels DS; Minnick MF
    Antimicrob Agents Chemother; 1998 Nov; 42(11):2906-13. PubMed ID: 9797224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. gyrB mutations in coumermycin A1-resistant Borrelia burgdorferi.
    Samuels DS; Marconi RT; Huang WM; Garon CF
    J Bacteriol; 1994 May; 176(10):3072-5. PubMed ID: 8188609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brachyspira (Serpulina) hyodysenteriae gyrB mutants and interstrain transfer of coumermycin A(1) resistance.
    Stanton TB; Matson EG; Humphrey SB
    Appl Environ Microbiol; 2001 May; 67(5):2037-43. PubMed ID: 11319078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic transformation of the Lyme disease agent Borrelia burgdorferi with coumarin-resistant gyrB.
    Samuels DS; Mach KE; Garon CF
    J Bacteriol; 1994 Oct; 176(19):6045-9. PubMed ID: 7928965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular characterization of the gyrB region of the oral spirochete, Treponema denticola.
    Greene SR; Stamm LV
    Gene; 2000 Aug; 253(2):259-69. PubMed ID: 10940564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quinolone resistance mutations in the DNA gyrase gyrA and gyrB genes of Staphylococcus aureus.
    Ito H; Yoshida H; Bogaki-Shonai M; Niga T; Hattori H; Nakamura S
    Antimicrob Agents Chemother; 1994 Sep; 38(9):2014-23. PubMed ID: 7811012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oligonucleotide-mediated genetic transformation of Borrelia burgdorferi.
    Samuels DS; Garon CF
    Microbiology (Reading); 1997 Feb; 143 ( Pt 2)():519-522. PubMed ID: 9043127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GyrB mutations in Staphylococcus aureus strains resistant to cyclothialidine, coumermycin, and novobiocin.
    Stieger M; Angehrn P; Wohlgensinger B; Gmünder H
    Antimicrob Agents Chemother; 1996 Apr; 40(4):1060-2. PubMed ID: 8849232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resistance genes of aminocoumarin producers: two type II topoisomerase genes confer resistance against coumermycin A1 and clorobiocin.
    Schmutz E; Mühlenweg A; Li SM; Heide L
    Antimicrob Agents Chemother; 2003 Mar; 47(3):869-77. PubMed ID: 12604514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An unusual mechanism for resistance to the antibiotic coumermycin A1.
    del Castillo I; Vizán JL; Rodríguez-Sáinz MC; Moreno F
    Proc Natl Acad Sci U S A; 1991 Oct; 88(19):8860-4. PubMed ID: 1656457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. gyrA mutations in ciprofloxacin-resistant Bartonella bacilliformis strains obtained in vitro.
    Minnick MF; Wilson ZR; Smitherman LS; Samuels DS
    Antimicrob Agents Chemother; 2003 Jan; 47(1):383-6. PubMed ID: 12499219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA gyrase activities from Rhodobacter capsulatus: analysis of target(s) of coumarins and cloning of the gyrB locus.
    Kranz RG; Beckman DL; Foster-Hartnett D
    FEMS Microbiol Lett; 1992 May; 72(1):25-32. PubMed ID: 1319375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. gyrB mutations which confer coumarin resistance also affect DNA supercoiling and ATP hydrolysis by Escherichia coli DNA gyrase.
    Contreras A; Maxwell A
    Mol Microbiol; 1992 Jun; 6(12):1617-24. PubMed ID: 1323022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutations in topoisomerase IV and DNA gyrase of Staphylococcus aureus: novel pleiotropic effects on quinolone and coumarin activity.
    Fournier B; Hooper DC
    Antimicrob Agents Chemother; 1998 Jan; 42(1):121-8. PubMed ID: 9449271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accumulation of mutations in both gyrB and parE genes is associated with high-level resistance to novobiocin in Staphylococcus aureus.
    Fujimoto-Nakamura M; Ito H; Oyamada Y; Nishino T; Yamagishi J
    Antimicrob Agents Chemother; 2005 Sep; 49(9):3810-5. PubMed ID: 16127057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New Escherichia coli gyrA and gyrB mutations which have a graded effect on DNA supercoiling.
    Aleixandre V; Urios A; Herrera G; Blanco M
    Mol Gen Genet; 1989 Oct; 219(1-2):306-12. PubMed ID: 2559316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular cloning of the gyrA and gyrB genes of Bacteroides fragilis encoding DNA gyrase.
    Onodera Y; Sato K
    Antimicrob Agents Chemother; 1999 Oct; 43(10):2423-9. PubMed ID: 10508019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cloning, functional expression, and complementation analysis of an inorganic pyrophosphatase from Bartonella bacilliformis.
    Mitchell SJ; Minnick MF
    Can J Microbiol; 1997 Aug; 43(8):734-43. PubMed ID: 9304784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Directed insertion of a selectable marker into a circular plasmid of Borrelia burgdorferi.
    Rosa P; Samuels DS; Hogan D; Stevenson B; Casjens S; Tilly K
    J Bacteriol; 1996 Oct; 178(20):5946-53. PubMed ID: 8830691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cloning and nucleotide sequence of Pseudomonas aeruginosa DNA gyrase gyrA gene from strain PAO1 and quinolone-resistant clinical isolates.
    Kureishi A; Diver JM; Beckthold B; Schollaardt T; Bryan LE
    Antimicrob Agents Chemother; 1994 Sep; 38(9):1944-52. PubMed ID: 7811002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.